glp-1 drug shortages Receptor Agonist Shortage: Challenges and Solutions in Type 2 Diabetes Care Most Patients Discontinue GLP-1 Drugs

doi: 10.1371/journal.pone.0082562

Peptide Vials (Ipamorelin, 5 mg each): 8 weeks 2 vials 12 weeks 4 vials 16 weeks 5 vials Insulin Syringes (U-100): Per week: 7 syringes (1/day) 8 weeks: 56 syringes 12 weeks: 84 syringes 16 weeks: 112 syringes Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution

doi: 10.1002/hep.29465 65

Hopefully, this makes it easier to figure out which one is best for you

Resolution or significant improvement in nagging injuries or chronic pain

[PubMed] [PMC] Eskridge W, Vierling JM, Gosbee W, Wan GA, Hyunh ML, Chang HE (2021) Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE)